Physician profile
Daniel Smith
NPI 1023081130
$2,256.06
in general payments reported to CMS, 2019-2025
22 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $285 · 2021: $467 · 2022: $133 · 2023: $365 · 2024: $384 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $382.82 | 2020-2025 | Skyrizi, Rinvoq |
| Sun Pharmaceutical Industries INC. | $328.66 | 2020-2025 | Blu-U, Odomzo, Ilumya |
| Amgen INC. | $201.89 | 2020-2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $187.65 | 2019-2025 | |
| Janssen Biotech, INC. | $122.29 | 2019-2023 | Tremfya |
| Genzyme Corporation | $120.54 | 2019-2025 | |
| Pfizer INC. | $98.69 | 2020-2023 | |
| Genentech USA, INC. | $92.52 | 2019 | |
| Lilly USA, LLC | $89.45 | 2019-2023 | Olumiant, Taltz |
| Dermavant Sciences, INC. | $87.02 | 2023-2024 | Vtama |
| Ucb, INC. | $86.49 | 2021-2024 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $84.46 | 2022-2024 | Sotyktu |
| Dusa Pharmaceuticals, INC. | $80.80 | 2019 | |
| Celgene Corporation | $73.91 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $71.07 | 2021-2024 | Dupixent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Helsinn Therapeutics (U.S.), INC. | $27.85 | 2021 | |
| Incyte Corporation | $24.64 | 2023 | Opzelura |
| Dermira, INC. | $23.87 | 2019 | |
| Botanix Sb INC | $22.75 | 2025 | Sofdra |
| Arcutis Biotherapeutics, INC. | $19.51 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.89 | 2019 | |
| Kyowa Kirin, INC. | $11.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.